Similarly, TTP was shown to destabilize interleukin 8 (IL-8) and vascular endothelial growth factor (VEGF) mRNAs in malignant glioma cells, resulting in a dose-dependent decrease in cellular proliferation, loss of cell viability, and apoptosis. This evidence concerns the gene CXCL8 and malignant glioma.